You are here

Cara Livernois
News Writer
As a News Writer at TriMed Media Group, Cara covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Patients with type 1 diabetes experienced higher levels of treatment satisfaction and lower distress levels when using a bionic pancreas (BP), according to a study published by Mary Ann Liebert.

Blue Cross and Blue Shield has announced a partnership with Onduo, an Alphabet-backed wearable device for the monitoring of glucose levels in diabetic patients.

Researchers from Dartmouth, Stanford University and IBM Research have conducted a review of literature to evaluate the feasibility of using social media data to identify behavioral patterns of prescription drug abuse. Findings are published in Journal of Medical Internet Research.

 - arthritic hands

According to a study conducted by the Children's Hospital of Philadelphia (CHOP) and published in JAMA Dermatology, parents that send high-quality photos from a smartphone camera of their child’s skin condition to dermatologists could skip the office visits and receive treatment through telehealth.

The incorporation of machine learning in clinical trials could improve research of effective drug treatments in the brain. It could also provide information on drug side-effects previously missed by conventional statistical tests, according to a study published in Brain.

Text message reminders were found to be an effective, low-cost method to increase influenza vaccinations, according to a study published in the Annals of Family Medicine.

While platforms such as Facebook, Twitter and Instagram give people the ability to connect with anyone in the world, the American Medical Association (AMA) has announced the adoption of new policies outlining the negative health effects of social media.

The CRISPR gene-editing tool could be used to better understand addiction and possibly develop methods of “addiction- proofing” the brain, according to research presented at Neuroscience 2017.

 - SmartphoneMed

The U.S. Food and Drug Administration (FDA) has approved the first digital pill with an ingestion tracking system to tell physicians whether patients have taken their medication.

The National Health Service (NHS) of the United Kingdom has released a free, 24-hour telehealth service administered through a user’s smartphone. The application initially covers 3.5 million patients in London.